http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04327534-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf79ed320aa28ececb761fe4908ee6f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad372b25387d99adde40b1f088e67542
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1991-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_255e95ac18109d74ce6515d85177ce28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70deaa6ce8a7a8b4d58efb0d5429c413
publicationDate 1992-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04327534-A
titleOfInvention Agent for preventing and treating disorder of human body caused by active oxygen
abstract PURPOSE: To use a safe compound, iron chlorophyllin, for preventing or treating the disorders of human bodies caused by active oxygen which is considered to cause the various disorders of the human bodies such as cancer, cardiac infarction and diabete and the deterioration of cosmetics. n CONSTITUTION: A agent for preventing and treating the disorders of human bodies caused by active oxygen, containing iron chlorophyllin as an active ingredient. The iron chlorophyllin is obtained by removing magnesium from chlorophyllin with an acid, saponifying the produced pheophytin with an alkali, and subsequently compounding the produced phytochlorin with iron. The agent is used for preventing and treating disorders, e.g. aging, congenital abnormal diseases, asthma, sepsis, angiopathy, arterial sclerosis, nephritis, cataract, skin diseases such as psoriasis, cancer, cardiac infarction, diabete, rheumatism, cerebral edema, chronic pulmonary emphysema, various ischemia and autoimmunity. The deterioration of the qualities of fats, oils, etc., in foods or cosmetics is prevented. The agent is generally preferably employed in an amount of approximately ≤5g/kg. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016210540-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005104874-A1
priorityDate 1991-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5479494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136387837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453187150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228921192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185

Total number of triples: 29.